ArticleFrontiers in public health2025
Global, regional, and national burden of depressive disorders among women of childbearing age, 1990-2021: a joinpoint regression analysis for the Global Burden of Disease Study 2021.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Decoupled Global Trends in Zinc Deficiency-attributable Burden (GBD CRA) and Depressive Disorders, 1990-2021: a GBD 2021 Analysis.Biological trace element research · 2026Article
- ATP and major affective disorders: the involvement of P2X receptors in pathophysiology.Purinergic signalling · 2026Review
- Medicaid expansion and inpatient hospital charges among women with major depressive disorders.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Depressive disorders, as a mental disorder, are prevalent among women, particularly women of childbearing age (WCBA). However, comprehensive epidemiological studies on this population appear to be limited globally. To investigate the longitudinal epidemiology of depressive disorders among women aged 15-49 years worldwide. Method: Estimates of annual incidence, prevalence, and disability-adjusted life years (DALYs) of depressive disorders for seven age groups (15-49 years) of women were extracted from the 2021 Global Burden of Disease Study, including 95% uncertainty intervals (UI). Age-standardized incidence rates (ASIR), age-standardized prevalence rates (ASPR), and age-standardized DALYs rates (ASDR) of depressive disorders in this population were estimated using direct age-standardization. Joinpoint regression analysis was employed to assess temporal trends in depressive disorders among this cohort from 1990 to 2021. Result: From 1990 to 2021, ASIR, ASPR, and ASDR of depressive disorders among WCBA increased globally. Regionally, incidence, prevalence, and DALYs rates rose in high-income areas such as North America, while a decline was observed in East Asia. Among 204 countries, Greenland, the United States of America, and Greece reported the highest ASIR, ASPR, and ASDR in 2021, with Mexico exhibiting the fastest increase. Additionally, from 2019 to 2021, most countries and regions worldwide experienced a continuous rise in the burden of depressive disorders among WCBA. Conclusion: Our study provides accurate age-standardized estimates, facilitating effective comparisons across different regions. We found a sharp increase in the global burden of depressive disorders among WCBA in almost all countries and regions after 2019, highlighting an urgent need for governments to develop flexible health policies to mitigate the escalating threat of depressive disorders in this demographic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.